Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

for
Sjögren's Syndrome
Location: Vandalia OH, Miamisburg OH, Toledo OH,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06747949

Phase3, Recruiting

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

for
Hypertriglyceridemia
Location: Vandalia OH, Columbus OH, London, Kitchener,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06822790

Phase3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: Englewood OH, Middletown OH, Cincinnati OH, Dublin OH,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

for
Palmoplantar Pustulosis
Location: Fairborn OH, Columbus OH, Mayfield Heights OH,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07219420

Phase3, Recruiting

Mechanisms for Laser-Induced Rejuvenation

for
Skin Cancer
Location: Fairborn OH
Sponsor: Wright State University

Sex: All

Age: 18+

Code: NCT06489301

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: Miamisburg OH, Columbus OH, Lexington KY, New Albany IN,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Springboro OH, Akron OH, Chattanooga TN, St Louis MO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase3, Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Springboro OH, Akron OH, Westlake OH, Chattanooga TN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for
Metabolic Dysfunction Associated Steatohepatitis
Location: Springboro OH, Columbus OH, Westlake OH, South Bend IN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632457

Phase3, Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for
Metabolic Dysfunction Associated Steatohepatitis (MASH),
Location: Springboro OH, Columbus OH, Westlake OH, South Bend IN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632444

Phase3, Recruiting

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for
Gout
Location: Dayton OH, Brownsburg IN, Louisville KY, Ann Arbor MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089875

Phase3, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for
Tophaceous Gout
Location: Dayton OH, Louisville KY, Ann Arbor MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Springfield OH, Richmond IN, Indianapolis IN,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Springfield OH, Cincinnati OH, Muncie IN, Elkhart IN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Springfield OH, Wilmington OH, Cincinnati OH,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase2, Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

for
Atrial Fibrillation
Location: Springfield OH, Cincinnati OH, Ypsilanti MI,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 22+

Code: NCT07227532

Recruiting

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: Springfield OH, Fort Wayne IN, Youngstown OH,
Sponsor: Luminate Medical, Inc.

Sex: All

Age: 18+

Code: NCT07142304

Recruiting

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

for
Colorectal Cancer, Sarcopenia
Location: Springfield OH, Columbus OH, Chillicothe OH, Newark OH,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 60+

Code: NCT03998202

Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Springfield OH, Cleveland OH, Troy MI, Chicago IL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase3, Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Liberty Township OH, Cincinnati OH, Ypsilanti MI,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase2, Recruiting